CIK 0001279704
- Non-accelerated filer
- Smaller reporting company
Cellectar Biosciences, Inc.
Sign in to watch- Ticker
- CLRB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 043321804
- Phone
- +1 608-441-8120
- Business address
- 100 CAMPUS DRIVE, FLORHAM PARK, NJ, 07932
- Former names
- NOVELOS THERAPEUTICS, INC., COMMON HORIZONS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-07-07 | CARUSO JAMES V President & CEO | Grant or award · Stock option (right to buy) | +250,000 | 250,000 | ||
| 2026-05-07 | CARUSO JAMES V Chief Executive Officer | Purchase | +8,680 | $2.88 | $25K | 20,318 |
| 2026-05-07 | CARUSO JAMES V Chief Executive Officer | Purchase · Warrants | +26,040 | $0.01 | $260 | 36,076 |
| 2025-07-02 | CARUSO JAMES V Chief Executive Officer | Purchase | +10,000 | $4.99 | $50K | 11,638 |
| 2025-07-02 | CARUSO JAMES V Chief Executive Officer | Purchase · Warrants | +10,000 | $0.01 | $100 | 10,000 |
| 2025-02-14 | CARUSO JAMES V President and CEO | Grant or award · Stock option (right to buy) | +900,000 | 900,000 | ||
| 2024-06-14 | CARUSO JAMES V President and CEO | Grant or award · Stock option (right to buy) | +900,000 | 900,000 | ||
| 2023-12-08 | CARUSO JAMES V President and CEO | Grant or award | +40,596 | 49,236 | ||
| 2023-06-23 | CARUSO JAMES V President and CEO | Grant or award · Stock option (right to buy) | +261,000 | 261,000 | ||
| 2023-01-17 | CARUSO JAMES V President and CEO | Grant or award · Stock option (right to buy) | +261,000 | 261,000 | ||
| 2022-01-25 | CARUSO JAMES V President and CEO | Grant or award · Stock option (right to buy) | +1,419,000 | 1,419,000 | ||
| 2021-03-04 | CARUSO JAMES V President and CEO | Purchase | +5,100 | $1.70 | $9K | 86,401 |
| 2021-03-04 | CARUSO JAMES V President and CEO | Grant or award · Stock option (right to buy) | +1,600,000 | 1,600,000 | ||
| 2021-03-04 | CARUSO JAMES V President and CEO | Sale · Series A Warrants | +46,948 | $0.19 | $9K | 0 |
| 2020-12-28 | CARUSO JAMES V President and CEO | Purchase | +37,037 | $1.35 | $50K | 81,301 |
| 2020-06-05 | CARUSO JAMES V President and CEO | Purchase | +21,740 | $1.15 | $25K | 44,264 |
| 2020-06-05 | CARUSO JAMES V President and CEO | Purchase · Series H Warrants | +10,870 | $0.01 | $109 | 10,870 |
| 2020-02-03 | CARUSO JAMES V President and CEO | Grant or award · Stock option (right to buy) | +100,000 | 100,000 | ||
| 2020-02-03 | CARUSO JAMES V President and CEO | Grant or award | +100,000 | $2.71 | $271K | 100,000 |
| 2019-01-17 | CARUSO JAMES V President and CEO | Grant or award · Stock option (right to buy) | +75,000 | 75,000 |
Page 1 of 2 · 31 trades